CIK 0001680581
- Non-accelerated filer
- Smaller reporting company
Fulcrum Therapeutics, Inc.
Sign in to watch- Ticker
- FULC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474839948
- Phone
- +1 617-651-8851
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-10 | Moxham Christopher Chief Scientific Officer | Exercise or conversion | +20,714 | $7.84 | $162K | 20,714 |
| 2021-08-10 | Moxham Christopher Chief Scientific Officer | Sale | −20,714 | $17.00 | $352K | 0 |
| 2021-08-10 | Moxham Christopher Chief Scientific Officer | Exercise or conversion | +31,071 | $7.84 | $244K | 31,071 |
| 2021-08-10 | Moxham Christopher Chief Scientific Officer | Sale | −31,071 | $18.00 | $559K | 0 |
| 2021-08-10 | Moxham Christopher Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −20,714 | 103,572 | ||
| 2021-08-10 | Moxham Christopher Chief Scientific Officer | Exercise or conversion · Stock Option (right to buy) | −31,071 | 72,501 | ||
| 2021-02-08 | Moxham Christopher Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 |
Page 1 of 1 · 7 trades